The State of Nebulizer Therapy in Russian Federation

NCT05617079 | Active Not Recruiting

• 1 other identifier: FARCT0004
• Study Type: observational
• Target: 370
• Locations: 1 country
• Sites: 1

Brief Summary

It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins. Searching PubMed data for the last 5 years (2017-2022) for the keywords "nebulizer therapy" revealed 533 publications, and "mesh nebulizer therapy" - only 25 sources. During the same period, the national database (E-Library) has 75 publications for the keywords "nebulizer therapy", and 4 sources for "mesh nebulizer therapy". It should be noted that almost all publications are devoted to the use of nebulizers for specific diseases and pathological syndromes. There are no works evaluating the adherence of specialists, systemic indications and actually used methods. The aim of trial is to study the current state of the use of nebulizer therapy in medical organizations and identify ways to improve its effectiveness This study is planned to be carried out using a questionnaire using a database based on the Internet electronic survey form.

Conditions

Survey; Respiratory Failure; Respiratory Disease

Outcome Measures

Primary Outcomes (1)

• Structure of indications, methods and frequency of use of nebulizer therapy

  Registration of the structure and indications for nebulizer therapy

  up to 1 month after inclusion

Secondary Outcomes (2)

• Drugs and frequency of their use during nebulizer therapy

  up to 6 month after inclusion

• The frequency of use of nebulizer therapy for high-flow oxygen therapy, non-invasive ventilation and mechanical ventilation

  up to 6 month after inclusion

Study Arms (1)

Medicine physicians

Anesthesiologists, intensive care specialists, heads of departments of anesthesiology and intensive care, deputy chief physicians for anesthesiology and intensive care (heads of centers), employees of the department of anesthesiology and intensive care, pulmonologists working in medical organizations that use nebulizer therapy.

Other: Survey

Interventions

Survey OTHER

an electronic survey will be conducted

Medicine physicians

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Medicine physicians (VMP) practicing in the hospital and in the community settings.

You may qualify if:

• Medical physicians

You may not qualify if:

• Lack of experience in conducting nebulizer therapy. Lack of technical capability for nebulizer therapy in a medical organization.

Sponsors & Collaborators

• Russian Federation of Anesthesiologists and Reanimatologists: lead

Study Sites (1)

Alexey Gritsan

Krasnoyarsk, Russia

Location

MeSH Terms

Conditions

Respiratory Insufficiency; Respiration Disorders

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Alexey Gritsan, MD

  Krasnoyarsk State Medical University n.a. prof. V.F. Voyno-Yasenetsky

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 7, 2022
• First Posted: November 15, 2022
• Study Start: July 1, 2023
• Primary Completion: June 30, 2024
• Study Completion: July 31, 2025
• Last Updated: April 4, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

RU (1)